🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study is a multi-site Phase 3 double-blinded randomized placebo-control...
Status
Withdrawn
Location
University of Texas Health Science Center at San Antonio
Start Date
2018-11-01
Trial ID
NCT03298958
Treatments Being Tested
The investigators will do the study in two phases. The first phase will be ...
Status
Completed
Location
Mayo Clinic in Rochester and Mayo Health System sites in Austin and Albert Lea, Minnesota
Start Date
2012-08
Trial ID
NCT01649960
Treatments Being Tested
Over the past decades, healthcare systems face significant challenges to me...
Status
Recruiting
Location
UT Southwestern Medical Center
Start Date
2026-05-11
Trial ID
NCT06727305
The study will assess the safety and efficacy of Everolimus (RAD001) alone ...
Status
Terminated
Location
Retina-Vitreous Associates Medical Group
Start Date
2009-02
Trial ID
NCT00857259
Treatments Being Tested
Background: Advanced liver scarring leads to liver failure, liver cancer an...
Status
Completed
Location
Queen's Medical Centre, Nottingham University Hospitals NHS Trust
Start Date
2022-07-25
Trial ID
NCT05663944
Treatments Being Tested
This trial evaluated the efficacy and safety of Everolimus in combination w...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-05-24
Trial ID
NCT01551212
Treatments Being Tested
WXFL10030390 (WX390) is a novel oral small molecular that inhibits phosphoi...
Status
Completed
Location
Shanghai East Hospital
Start Date
2018-10-25
Trial ID
NCT03730142
Treatments Being Tested
The primary objective of this trial is to show non-inferiority of a CNI-fre...
Status
Completed
Location
Novartis Investigative Site
Start Date
2009-12
Trial ID
NCT00965094
The primary purpose of this study is to determine whether the drug sirolimu...
Status
Active Not Recruiting
Location
University of Chicago
Start Date
2021-07-09
Trial ID
NCT04948203
Treatments Being Tested
The purpose of this study is to find the smallest amount of the 131 I-apami...
Status
Recruiting
Location
Columbia University Irving Medical Center
Start Date
2025-04-28
Trial ID
NCT07015684